Companies Report Earnings for Q3 2025: Dynex Cap, Summit Therapeutics, Cleveland-Cliffs, and More
PorAinvest
lunes, 20 de octubre de 2025, 8:28 pm ET1 min de lectura
CLF--
Dynex Capital reported quarterly earnings of $0.25 per share, missing the Zacks Consensus Estimate of $0.44 per share. This compares to a loss of $0.10 per share a year ago. The company's revenues for the quarter ended September 2025 were $30.61 million, surpassing the Zacks Consensus Estimate by 4.62%. Over the last four quarters, Dynex Capital has surpassed consensus EPS estimates just once. The stock has added about 5.8% since the beginning of the year versus the S&P 500's gain of 13.3% [1].
Summit Therapeutics Inc. (SMMT)
Summit Therapeutics reported a quarterly adjusted loss of 31 cents per share for the quarter ended September 30, lower than the same quarter last year. The mean expectation of fifteen analysts for the quarter was for a loss of 13 cents per share. Reported revenue was zero; analysts expected zero. The company's shares have risen by 1.6% this quarter and gained 17.6% so far this year [2].
Cleveland-Cliffs Inc. (CLF)
Cleveland-Cliffs is expected to report a quarterly loss at $0.46 per share on revenue of $4.89 billion. The company is a major steel producer and has been impacted by global steel market conditions. The exact earnings report is not yet available [3].
HBT Financial (HBT)
HBT Financial reported quarterly earnings of $0.65 per share, beating the Zacks Consensus Estimate of $0.62 per share. The company's revenues for the quarter ended September 2025 were $59.84 million, surpassing the Zacks Consensus Estimate by 0.06%. Over the last four quarters, HBT Financial has surpassed consensus EPS estimates four times. The stock has added about 7.8% since the beginning of the year versus the S&P 500's gain of 13.3% .
DX--
SMMT--
Dynex Cap is expected to report quarterly earnings at $0.33 per share on revenue of $31.78 million, while Summit Therapeutics is projected to report a quarterly loss at $0.08 per share on revenue of $56.92 million. Cleveland-Cliffs is estimated to report a quarterly loss at $0.46 per share on revenue of $4.89 billion, and HBT Financial is expected to report quarterly earnings at $0.62 per share on revenue of $60.07 million.
Dynex Capital (DX)Dynex Capital reported quarterly earnings of $0.25 per share, missing the Zacks Consensus Estimate of $0.44 per share. This compares to a loss of $0.10 per share a year ago. The company's revenues for the quarter ended September 2025 were $30.61 million, surpassing the Zacks Consensus Estimate by 4.62%. Over the last four quarters, Dynex Capital has surpassed consensus EPS estimates just once. The stock has added about 5.8% since the beginning of the year versus the S&P 500's gain of 13.3% [1].
Summit Therapeutics Inc. (SMMT)
Summit Therapeutics reported a quarterly adjusted loss of 31 cents per share for the quarter ended September 30, lower than the same quarter last year. The mean expectation of fifteen analysts for the quarter was for a loss of 13 cents per share. Reported revenue was zero; analysts expected zero. The company's shares have risen by 1.6% this quarter and gained 17.6% so far this year [2].
Cleveland-Cliffs Inc. (CLF)
Cleveland-Cliffs is expected to report a quarterly loss at $0.46 per share on revenue of $4.89 billion. The company is a major steel producer and has been impacted by global steel market conditions. The exact earnings report is not yet available [3].
HBT Financial (HBT)
HBT Financial reported quarterly earnings of $0.65 per share, beating the Zacks Consensus Estimate of $0.62 per share. The company's revenues for the quarter ended September 2025 were $59.84 million, surpassing the Zacks Consensus Estimate by 0.06%. Over the last four quarters, HBT Financial has surpassed consensus EPS estimates four times. The stock has added about 7.8% since the beginning of the year versus the S&P 500's gain of 13.3% .

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios